SPDR S&P Pharmaceuticals ETF Rating $41.28 +0.05 (+0.12%) As of 07/3/2025 05:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.71Holdings in XPH have an aggregate rating of Moderate Buy based on 380 analyst ratings issued in the past year covering 42 companies (99.6% of the portfolio).XPH Aggregate Price Target$41.28High Prediction$41.28Average Prediction$41.28Low Prediction$41.28Holdings in XPH have an aggregate price target of $41.28 and a range of $41.28 to $41.28 covering 42 companies (99.6% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.18%CORTCorcept Therapeutics$72.65+1.8%4.7057 of 5 stars3.00$138.25 90.3%5News Coverage5.13%ELANElanco Animal Health$14.64-0.5%2.4008 of 5 stars2.50$15.33 4.7%8News CoverageAnalyst Forecast4.25%RPRXRoyalty Pharma$36.33+0.4%4.9157 of 5 stars3.25$47.33 30.3%4Positive News3.83%ZTSZoetis$159.19+0.1%4.8383 of 5 stars3.00$212.13 33.3%10News CoveragePositive News3.83%PRGOPerrigo$27.20-0.2%4.8061 of 5 stars2.25$33.00 21.3%4Analyst Upgrade3.82%LLYEli Lilly and Company$779.60+0.0%4.9885 of 5 stars2.75$1,011.61 29.8%20Trending News3.81%PBHPrestige Consumer Healthcare$79.98-0.2%4.2084 of 5 stars2.50$93.33 16.7%6Positive NewsAnalyst Upgrade3.79%VTRSViatris$9.25-1.0%2.6598 of 5 stars1.80$10.40 12.4%53.71%PFEPfizer$25.45+0.5%4.9762 of 5 stars2.45$28.55 12.2%22Trending News3.70%JNJJohnson & Johnson$155.90+0.2%4.8452 of 5 stars2.55$170.88 9.6%20Positive News3.44%AXSMAxsome Therapeutics$105.36+1.4%4.7429 of 5 stars3.06$172.33 63.6%16Trending NewsAnalyst ForecastAnalyst Revision3.39%MRKMerck & Co., Inc.$80.97-1.7%4.9962 of 5 stars2.43$109.19 34.8%21Positive News3.31%TARSTarsus Pharmaceuticals$41.08+1.6%2.0685 of 5 stars3.00$66.67 62.3%7Positive News3.22%JAZZJazz Pharmaceuticals$109.45-0.4%4.9004 of 5 stars2.92$184.00 68.1%13Insider Trade3.13%BMYBristol Myers Squibb$47.02-1.3%4.9464 of 5 stars2.32$58.00 23.4%22Positive News3.00%HRMYHarmony Biosciences$32.09-0.1%4.7986 of 5 stars3.13$53.63 67.1%8Positive News2.99%PCRXPacira BioSciences$23.210.0%3.4572 of 5 stars2.33$26.44 14.0%92.63%OGNOrganon & Co.$10.08-0.7%4.8958 of 5 stars2.50$18.00 78.7%6Trending News2.52%AMPHAmphastar Pharmaceuticals$23.18-1.7%4.3658 of 5 stars2.25$32.33 39.5%4News Coverage2.31%HROWHarrow$31.78+4.0%2.6828 of 5 stars3.00$61.40 93.2%6Positive News2.30%ARVNArvinas$7.89-0.1%3.0993 of 5 stars2.55$20.29 157.1%222.19%SUPNSupernus Pharmaceuticals$32.00-0.2%2.828 of 5 stars2.33$36.00 12.5%3News Coverage2.17%EWTXEdgewise Therapeutics$12.96-0.4%2.4889 of 5 stars2.80$40.00 208.8%10News CoverageAnalyst Revision1.99%ANIPANI Pharmaceuticals$65.29+0.1%3.7136 of 5 stars3.00$80.13 22.7%91.95%LGNDLigand Pharmaceuticals$114.39+0.6%4.8099 of 5 stars3.00$146.14 27.8%7News Coverage1.86%INVAInnoviva$19.20-1.0%3.9013 of 5 stars3.00$55.00 186.5%21.85%COLLCollegium Pharmaceutical$30.37-0.5%4.1057 of 5 stars2.75$43.75 44.1%4News CoverageAnalyst Downgrade1.64%LQDALiquidia Technologies$12.25+1.5%3.2337 of 5 stars3.00$26.89 119.6%91.61%CRMDCorMedix$11.64+0.4%2.572 of 5 stars2.88$17.14 47.3%8Analyst Revision1.35%AMRXAmneal Pharmaceuticals$8.56+2.3%3.7842 of 5 stars3.00$11.60 35.5%51.20%MNMDMind Medicine (MindMed)$7.20+1.7%3.0567 of 5 stars3.27$25.50 254.2%11Positive News1.13%OCULOcular Therapeutix$9.36-1.1%3.9648 of 5 stars3.00$17.33 85.2%6Positive News1.11%WVEWAVE Life Sciences$6.97+3.3%4.3632 of 5 stars2.92$20.50 194.1%121.05%EYPTEyepoint Pharmaceuticals$9.83+1.8%2.4506 of 5 stars3.00$25.67 161.0%90.84%XERSXeris Biopharma$4.76+0.5%3.9135 of 5 stars2.83$6.25 31.4%6Positive News0.84%EOLSEvolus$9.27+0.7%3.6046 of 5 stars3.00$23.75 156.2%50.71%ELVNEnliven Therapeutics$20.68+0.2%2.5077 of 5 stars3.00$41.20 99.3%5Analyst ForecastAnalyst Revision0.69%NUVBNuvation Bio$2.09+1.7%3.4513 of 5 stars3.20$7.17 243.7%50.63%PAHCPhibro Animal Health$27.99+0.2%3.6484 of 5 stars1.67$21.80 -22.1%60.58%ZVRAZevra Therapeutics$9.79+4.0%2.7709 of 5 stars3.11$23.14 136.5%9News CoverageAnalyst ForecastAnalyst Revision0.55%ESPREsperion Therapeutics$1.17+1.8%4.1318 of 5 stars2.80$7.00 497.8%50.35%OMEROmeros$3.20+3.6%3.6736 of 5 stars2.83$18.00 462.3%6 This page (NYSEARCA:XPH) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
